Mark J. Gergen
2020 - Poseida Therapeutics
In 2020, Mark J. Gergen earned a total compensation of $1.4M as Chief Executive Officer and President and former Chief Business Officer at Poseida Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $194,710 |
---|---|
Option Awards | $804,500 |
Salary | $432,680 |
Other | $9,102 |
Total | $1,440,992 |
Gergen received $804.5K in option awards, accounting for 56% of the total pay in 2020.
Gergen also received $194.7K in non-equity incentive plan, $432.7K in salary and $9.1K in other compensation.
Rankings
In 2020, Mark J. Gergen's compensation ranked 7,001st out of 13,090 executives tracked by ExecPay. In other words, Gergen earned more than 46.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,001 | 47th |
Manufacturing | 2,922 | 48th |
Chemicals And Allied Products | 1,181 | 48th |
Drugs | 1,015 | 48th |
Biological Products, Except Diagnostic Substances | 244 | 41st |
Gergen's colleagues
We found two more compensation records of executives who worked with Mark J. Gergen at Poseida Therapeutics in 2020.